Pulse Biosciences, Inc. Deferred Tax Liabilities, Other Finite-Lived Assets
Pulse Biosciences, Inc. (PLSE) had Deferred Tax Liabilities, Other Finite-Lived Assets of $28.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets · last filed 2022-03-31
- 2021-12-31: Deferred Tax Liabilities, Other Finite-Lived Assets $28.00K.
- 2020-12-31: Deferred Tax Liabilities, Other Finite-Lived Assets $31.00K.
| Period end | Deferred Tax Liabilities, Other Finite-Lived Assets |
|---|---|
| 2021-12-31 | $28.00K 10-K · filed 2022-03-31 |
| 2020-12-31 | $31.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |